4-AcO-EPT is classified as a novel tryptamine analogue. Tryptamine analogues are modified based on the structure of tryptamine. Tryptamine analogues have been reported to cause hallucinogenic effects, often associated with “psychedelic mushrooms.” Tryptamine
analogues have caused adverse events, including agitation, tachyarrhythmias, hyperpyrexia, and death, as described in the literature. Structurally similar compounds include psilocin, 4-HO-EPT, and 4-AcO-DPT, among several other tryptamine analogues. Psilocin is a Schedule I substance in the United States.

4-AcO-EPT (Hallucinogen): Announcement of Newly Identified Novel Psychoactive Substance (NPS) in the United States.

« Back to Glossary Index

Copyright © 2023 - NADDI. All Rights Reserved.

Disclaimer / Privacy Policy / Copyright Policy

Log in with your credentials

Forgot your details?